3D | pharmaphorum

Digital

The technology behind virtual reality is rapidly advancing, allowing developers to create entire 3D hospitals for training purposes.

News

Syndax shares lost 17% of their value pre-market after the company said it abandoned development of axatilimab for idiopathic pulmonary fibrosis.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

3D